PEGylation potentiates hepatoma cell targeted liposome-mediated in vitro gene delivery via the asialoglycoprotein receptor
- 7 January 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Zeitschrift für Naturforschung C
- Vol. 72 (7-8) , 293-301
Abstract
Hepatocellular carcinoma is a burgeoning health issue in sub-Saharan Africa and East Asia where it is most prevalent. The search for gene medicine treatment modalities for this condition represents a novel departure from current treatment options and is gaining momentum. Here we report on nonPEGylated and on sterically stabilized PEGylated cationic liposomes decorated with D-galacto moieties linked to 24.1 Å spacers for asialoglycoprotein receptor (ASGP-R)-targeted vehiculation of pCMV-luc plasmid DNA. Cargo DNA is fully liposome associated at N/P ratio=3:1 and is partially protected from the effects of serum nucleases. Moreover, at this ratio, lipoplex dimensions (89–97 nm) are compatible with the requirements for extravasation in vivo. Ethidium displacement assays show that the reporter DNA is in a less condensed state when bound to PEGylated liposomes than with nonPEGylated liposomes. PEGylated lipoplexes were well tolerated by both HEK293 (ASGP-R-negative) and HepG2 (ASGP-R-positive) cell lines and delivered DNA to the human hepatoma cell line HepG2 by ASGP-R mediation at levels three-fold greater than nonPEGylated lipoplexes. PEGylated ASGP-R-targeted liposomes reported in this study possess the required characteristics for hepatotropic gene delivery and may be considered for further application in vivo.Keywords
This publication has 45 references indexed in Scilit:
- Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomasNature Genetics, 2015
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyLiver International, 2015
- Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectorsGene Therapy, 2014
- Hepatocellular carcinoma review: Current treatment, and evidence-based medicineWorld Journal of Gastroenterology, 2014
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Progress and prospects: immune responses to viral vectorsGene Therapy, 2009
- Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burdenJournal of Viral Hepatitis, 2009
- Hepatitis B and hepatocellular carcinoma #Hepatology, 2009
- Treatment options for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology, 2008
- Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoterEuropean Journal of Cancer, 2001